ArticleBMC bioinformatics2020
Drug-target interaction prediction with tree-ensemble learning and output space reconstruction.
Article in BMC bioinformatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Drug-target interaction prediction based on graph convolutional autoencoder with dynamic weighting residual GCN.BMC bioinformatics · 2025Article
- QKDTI A quantum kernel based machine learning model for drug target interaction prediction.Scientific reports · 2025Article
- MCF-DTI: Multi-Scale Convolutional Local-Global Feature Fusion for Drug-Target Interaction Prediction.Molecules (Basel, Switzerland) · 2025Article
- An Enhanced Computational Approach Using Multi-kernel Positive Unlabeled Learning for Predicting Drug-target Interactions.Current computer-aided drug design · 2025Article
- The development and validation of a prognostic prediction modeling study in acute myocardial infarction patients after percutaneous coronary intervention: hemorrhea and major cardiovascular adverse events.Journal of thoracic disease · 2024Article
- Mining Chemogenomic Spaces for Prediction of Drug-Target Interactions.Methods in molecular biology (Clifton, N.J.) · 2024Article
- Comprehensive Review on Drug-target Interaction Prediction - Latest Developments and Overview.Current drug discovery technologies · 2024Review
- Drug-target interaction prediction based on protein features, using wrapper feature selection.Scientific reports · 2023Article
- Comparative Studies on Resampling Techniques in Machine Learning and Deep Learning Models for Drug-Target Interaction Prediction.Molecules (Basel, Switzerland) · 2023Review
- Benzoquinoline Chemical Space: A Helpful Approach in Antibacterial and Anticancer Drug Design.Molecules (Basel, Switzerland) · 2023Article
- A novel method for drug-target interaction prediction based on graph transformers model.BMC bioinformatics · 2022Article
- Machine intelligence-driven framework for optimized hit selection in virtual screening.Journal of cheminformatics · 2022Article
- Detecting Drug-Target Interactions with Feature Similarity Fusion and Molecular Graphs.Biology · 2022Article
- Molecular docking of DS-3032B, a mouse double minute 2 enzyme antagonist with potential for oncology treatment development.World journal of clinical oncology · 2022Article
- Novel drug-target interactions via link prediction and network embedding.BMC bioinformatics · 2022Article
- Differential diagnostic value of the ResNet50, random forest, and DS ensemble models for papillary thyroid carcinoma and other thyroid nodules.The Journal of international medical research · 2022Article
- A Novel Deep Neural Network Technique for Drug-Target Interaction.Pharmaceutics · 2022Article
- Drug-target interaction prediction via multiple classification strategies.BMC bioinformatics · 2022Article
- Drug repositioning based on heterogeneous networks and variational graph autoencoders.Frontiers in pharmacology · 2022Article
- DTI-HeNE: a novel method for drug-target interaction prediction based on heterogeneous network embedding.BMC bioinformatics · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundComputational prediction of drug-target interactions (DTI) is vital for drug discovery. The experimental identification of interactions between drugs and target proteins is very onerous. Modern technologies have mitigated the problem, leveraging the development of new drugs. However, drug development remains extremely expensive and time consuming. Therefore, in silico DTI predictions based on machine learning can alleviate the burdensome task of drug development. Many machine learning approaches have been proposed over the years for DTI prediction. Nevertheless, prediction accuracy and efficiency are persisting problems that still need to be tackled. Here, we propose a new learning method which addresses DTI prediction as a multi-output prediction task by learning ensembles of multi-output bi-clustering trees (eBICT) on reconstructed networks. In our setting, the nodes of a DTI network (drugs and proteins) are represented by features (background information). The interactions between the nodes of a DTI network are modeled as an interaction matrix and compose the output space in our problem. The proposed approach integrates background information from both drug and target protein spaces into the same global network framework.
resultsWe performed an empirical evaluation, comparing the proposed approach to state of the art DTI prediction methods and demonstrated the effectiveness of the proposed approach in different prediction settings. For evaluation purposes, we used several benchmark datasets that represent drug-protein networks. We show that output space reconstruction can boost the predictive performance of tree-ensemble learning methods, yielding more accurate DTI predictions.
conclusionsWe proposed a new DTI prediction method where bi-clustering trees are built on reconstructed networks. Building tree-ensemble learning models with output space reconstruction leads to superior prediction results, while preserving the advantages of tree-ensembles, such as scalability, interpretability and inductive setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.